| NDC Code | 10122-620-10 |
|---|
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (10122-620-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (10122-620-01) |
|---|
| Product NDC | 10122-620 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Kengreal |
|---|
| Non-Proprietary Name | Cangrelor |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20150708 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA204958 |
|---|
| Manufacturer | Chiesi USA, Inc. |
|---|
| Substance Name | CANGRELOR |
|---|
| Strength | 50 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA] |
|---|